CLINICAL_TRIALS
trial_result
· 2021-03-08
Clinical Trial Update: Targeted Retreatment of COPD Exacerbations [Phase 3]
Summary
A Phase 3 clinical trial investigating targeted retreatment of COPD exacerbations has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Imperial College London | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED | Results posted: 2021-03-08